Literature DB >> 12787919

Advanced glycation endproducts as UVA photosensitizers of tryptophan and ascorbic acid: consequences for the lens.

Arnauld de La Rochette1, Inès Birlouez-Aragon, Eduardo Silva, Patrice Morlière.   

Abstract

Upon aging, the lens accumulates brown fluorophores, mainly derived from the Maillard reaction between vitamin C oxidation products and crystallins lysine residues. At the same time, the concentration of UVA filters decreases, allowing some radiation to be absorbed by lenticular advanced glycation endproducts (AGEs). This paper quantifies the photosensitizing activity of AGEs at various oxygen pressures, and compares it to that of lenticular riboflavin (RF). Solutions containing the sensitizer and the substrates tryptophan (Trp) and ascorbate (AH(-)) were irradiated at 365 nm. We show that the AGEs-photosensitized Trp oxidation rate increases with AGEs concentration and is optimal at 5% oxygen, the pressure in the lens. By contrast, for AH(-), the photooxidation rate increases with oxygen concentration. Despite the higher quantum yield of RF-depending reactions, its low concentration as compared to that of AGEs in aging lenses induces significantly higher Trp and AH(-) photodegradation rates with AGEs than with RF. As ascorbate is more rapidly photodegraded than Trp, the antioxidant competitively protects Trp from oxidation up to 1 mM, although not absolutely. We conclude that in the aging lens, AH(-) exerts a strong UVA protecting activity, but does not impede some Trp residue to be photodegraded proportionally to the AGEs concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787919     DOI: 10.1016/s0304-4165(03)00072-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Phototoxicity of environmental radiations in human lens: revisiting the pathogenesis of UV-induced cataract.

Authors:  Farzin Kamari; Shahin Hallaj; Fatemeh Dorosti; Farbod Alinezhad; Negar Taleschian-Tabrizi; Fereshteh Farhadi; Hassan Aslani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-21       Impact factor: 3.117

2.  Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking.

Authors:  Yuntao Zhang; Abigail H Conrad; Gary W Conrad
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

3.  Oxidative damage of lysozyme and human serum albumin and their mixtures: a comparison of photosensitized and peroxyl radical promoted processes.

Authors:  Andrea Arenas; Rodrigo Vasquez; Camilo López-Alarcón; Eduardo Lissi; Eduardo Silva
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

4.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

5.  UVA light-excited kynurenines oxidize ascorbate and modify lens proteins through the formation of advanced glycation end products: implications for human lens aging and cataract formation.

Authors:  Mikhail Linetsky; Cibin T Raghavan; Kaid Johar; Xingjun Fan; Vincent M Monnier; Abhay R Vasavada; Ram H Nagaraj
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

6.  Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA).

Authors:  A Scott McCall; Stefan Kraft; Henry F Edelhauser; George W Kidder; Richard R Lundquist; Helen E Bradshaw; Zinaida Dedeic; Megan J C Dionne; Ethan M Clement; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

7.  Simulated Sunlight Selectively Modifies Maillard Reaction Products in a Wide Array of Chemical Reactions.

Authors:  Daniel Hemmler; Michael Gonsior; Leanne C Powers; James W Marshall; Michael Rychlik; Andrew J Taylor; Philippe Schmitt-Kopplin
Journal:  Chemistry       Date:  2019-09-13       Impact factor: 5.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.